Septerna has a market cap of $750mn and $130mn in cash and ST investments. Discover SEPN's groundbreaking drug discovery ...
What's the most attractive weight-loss stock right now? We asked Seeking Alpha analysts Edmund Ingham, Stephen Ayers and Oneil Trader for their picks. Read more here.
Obesity significantly impacts cardiovascular health, increasing risks such as left ventricular hypertrophy, atherosclerosis, and hypertension. Pharmaceuticals play a crucial role in addressing these ...
FREE TO READ] Critics say fragmented ownership, weak culture and a fixation on financial results have harmed innovation ...
Ozempic and other GLP-1 agonists are helping millions with weight loss but concerns grow over their long-term effects. Recent ...
2d
From cabbage soup to the F-plan, quick fix diets promise everything from miracle weight loss to eternal youth – but do any of ...
Weight-loss drugs are transforming health care and Wall Street, but exciting prospects don’t necessarily mean a company is a good investment.
FundCanna is redefining cannabis financing with flexible loans, fueling 61% average growth for operators, and solving ...
Dick's Drive-In is celebrating the chain's 71st anniversary with 19-cent hamburgers and cheeseburgers at all nine of its ...
The American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS), the world's largest association of facial plastic ...
By Dana G. Smith and Dani Blum Over a decade ago, a smattering of studies suggested that early cousins of drugs like Ozempic and Mounjaro could prevent, or even reverse, signs of Alzheimer’s ...
The FDA has approved a new indication for semaglutide to lower the risk for worsening kidney disease, kidney failure and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback